ClinicalTrials.Veeva

Menu

Treatment of Aggressive Localized Lymphoma

F

French Innovative Leukemia Organisation

Status and phase

Terminated
Phase 3

Conditions

B Cell Lymphoma

Treatments

Drug: rituximab
Procedure: radiotherapy
Drug: vincristine
Drug: prednisone
Drug: doxorubicin

Study type

Interventional

Funder types

Other

Identifiers

NCT00841945
GOELAMS 02 03

Details and patient eligibility

About

Prospective and multicentric Phase III study, evaluation of the interest of the radiotherapy after 4 or 6 cycles of CHOP 14 R regimen of chemotherapy , patients with agressive and localized B lymphoma , age 18 to 75 years.

Full description

CHOP 14 R regimen of chemotherapy is a good standard in the treatment of agressive and localized B lymphoma.

Interest of the radiotheraphy

Enrollment

334 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 and < 75 years
  • Diffuse B large cell lymphoma , CD 20+
  • Ann Arbor stage I or II withe a bulk <7 cm
  • stage i ou II confirmed by the PET-scan
  • No previously treated
  • HIV negative
  • Signed Informed consent

Exclusion criteria

  • Age< 18 and > 75 years
  • other type of lymphoma
  • CD20 negative
  • Ann Arbor stage >II or bulk > 7 cm
  • HIV positive
  • Contraindication to Rituximab use according to Sm PC
  • Containdication to antracyclin
  • cancer or history of cancer , excepted in situ cancer of the cervix or skin epithelioma
  • Refusal of sign the informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

334 participants in 2 patient groups

1
Active Comparator group
Description:
Chemotherapy + Radiotherapy - 4 or 6 R CHOP courses regimen every 14 days R CHOP = Rituximab, Doxorubicin, Vincristine and prednisone * Radiotherapy 40 gray on initial nodes
Treatment:
Drug: doxorubicin
Drug: prednisone
Procedure: radiotherapy
Drug: vincristine
Drug: rituximab
2
Experimental group
Description:
Chemotherapy - 4 or 6 R CHOP courses regimen every 14 days R CHOP = Rituximab, Doxorubicin, Vincristine and prednisone
Treatment:
Drug: doxorubicin
Drug: prednisone
Drug: vincristine
Drug: rituximab

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems